
### [MONDO:0016362](http://purl.obolibrary.org/obo/MONDO_0016362)
**Label:** attenuated familial adenomatous polyposis

**Subclasses:** [MONDO:0018426](http://purl.obolibrary.org/obo/MONDO_0018426) (AXIN2-related attenuated familial adenomatous polyposis), [MONDO:0014630](http://purl.obolibrary.org/obo/MONDO_0014630) (NTHL1-related attenuated familial adenomatous polyposis), [MONDO:0018812](http://purl.obolibrary.org/obo/MONDO_0018812) (MSH3-related attenuated familial adenomatous polyposis), [MONDO:0012041](http://purl.obolibrary.org/obo/MONDO_0012041) (MUTYH-related attenuated familial adenomatous polyposis), [MONDO:0014038](http://purl.obolibrary.org/obo/MONDO_0014038) (colorectal cancer, susceptibility to, 12), [MONDO:0018653](http://purl.obolibrary.org/obo/MONDO_0018653) (Polymerase proofreading-related adenomatous polyposis), [MONDO:0019336](http://purl.obolibrary.org/obo/MONDO_0019336) (Gardner syndrome), [MONDO:0016860](http://purl.obolibrary.org/obo/MONDO_0016860) (familial adenomatous polyposis due to 5q22.2 microdeletion), [MONDO:0012953](http://purl.obolibrary.org/obo/MONDO_0012953) (colorectal cancer, susceptibility to, 10), [MONDO:0008279](http://purl.obolibrary.org/obo/MONDO_0008279) (familial adenomatous polyposis type 1), [MONDO:0020497](http://purl.obolibrary.org/obo/MONDO_0020497) (Turcot syndrome with polyposis), [MONDO:0016613](http://purl.obolibrary.org/obo/MONDO_0016613) (APC-related attenuated familial adenomatous polyposis), 

**Corr. equiv. classes:** [Orphanet:480536](http://www.orpha.net/ORDO/Orphanet_480536), [Orphanet:261584](http://www.orpha.net/ORDO/Orphanet_261584), [OMIM:615083](http://purl.obolibrary.org/obo/OMIM_615083), [Orphanet:401911](http://www.orpha.net/ORDO/Orphanet_401911), [Orphanet:454840](http://www.orpha.net/ORDO/Orphanet_454840), [OMIM:612591](http://purl.obolibrary.org/obo/OMIM_612591), [Orphanet:247798](http://www.orpha.net/ORDO/Orphanet_247798), [OMIM:175100](http://purl.obolibrary.org/obo/OMIM_175100), [OMIM:616415](http://purl.obolibrary.org/obo/OMIM_616415), [Orphanet:99818](http://www.orpha.net/ORDO/Orphanet_99818), [Orphanet:247806](http://www.orpha.net/ORDO/Orphanet_247806), [OMIM:608456](http://purl.obolibrary.org/obo/OMIM_608456), [Orphanet:447877](http://www.orpha.net/ORDO/Orphanet_447877), [Orphanet:733](http://www.orpha.net/ORDO/Orphanet_733), [Orphanet:79665](http://www.orpha.net/ORDO/Orphanet_79665), 

**Class expressions from DL-Learner:**

- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0030255](http://purl.obolibrary.org/obo/HP_0030255) (Large intestinal polyposis) 58.05%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0030255](http://purl.obolibrary.org/obo/HP_0030255) (Large intestinal polyposis) and [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 58.05%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002250](http://purl.obolibrary.org/obo/HP_0002250) (Abnormality of the large intestine) and [HP:0030255](http://purl.obolibrary.org/obo/HP_0030255) (Large intestinal polyposis) 58.05%
- [HP:0030255](http://purl.obolibrary.org/obo/HP_0030255) (Large intestinal polyposis) and [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 50.38%
- [HP:0002250](http://purl.obolibrary.org/obo/HP_0002250) (Abnormality of the large intestine) and [HP:0030255](http://purl.obolibrary.org/obo/HP_0030255) (Large intestinal polyposis) 50.38%
- [HP:0030255](http://purl.obolibrary.org/obo/HP_0030255) (Large intestinal polyposis) 48.94%
- [HP:0200008](http://purl.obolibrary.org/obo/HP_0200008) (Intestinal polyposis) 37.43%
- [HP:0005266](http://purl.obolibrary.org/obo/HP_0005266) (Intestinal polyp) 34.80%
- [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 33.72%
- [HP:0007378](http://purl.obolibrary.org/obo/HP_0007378) (Neoplasm of the gastrointestinal tract) 25.80%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 24.15%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 23.95%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 21.25%
- Thing 21.24%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 21.24%


